Gland Pharma Limited IPO (Gland Pharma IPO) Detail
ABOUT THE COMPANY:
Gland Pharma Limited is Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets.Company operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.
Gland Pharma has seven manufacturing facilities in India, comprising four finished formulations facilities with a total of 22 production lines and three API facilities.
Company has increased our manufacturing capacities from 670 million units per annum in
Fiscal 2018 to 755 million as of March 31, 2020 and are expanding our manufacturing footprint in order to increase our product development and manufacturing capabilities.
Revenue from operations based on the Customer:
PROMOTERS OF GLAND PHARMA LIMITED:
- Mr. Yiu Kwan Stanley Lau Chairman and Independent Director
- Mr. Srinivas Sadu MD and CEO
TOP SHAREHOLDERS OF GLAND PHARMA LIMITED:
Financials of the Gland Pharma Limited
| (in Crores) | FY 18 | FY 19 | FY 20 | 30th June 2020 |
|---|---|---|---|---|
| Revenue | 1671.6 | 2129.7 | 2772.4 | 916.2 |
| Net Profit | 320.5 | 451.6 | 767.6 | 313.5 |
-
Objects of the ipo:
The net proceeds from the IPO will be used for the following purposes:
- Funding incremental working capital requirements of our Company;
- Funding capital expenditure requirements of our Company.
- General corporate purposes.
Gland Pharma Limited IPO Details:
| IPO Date | Nov 9, 2020 – Nov 11, 2020 |
| Issue Type | Book Built Issue IPO |
| Issue Size | 43,196,968 Eq Shares of ₹1 (aggregating up to ₹6,479.55 Cr) |
| Fresh Issue | 8,333,333 Eq Shares of ₹1 (aggregating up to ₹1,250.00 Cr) |
| Offer for Sale | 34,863,635 Eq Shares of ₹1 (aggregating up to ₹5,229.55 Cr) |
| Face Value | ₹1 per equity share |
| IPO Price | ₹1490 to ₹1500 per equity share |
| Market Lot | 10 Shares |
| Min Order Quantity | 10 Shares |
| Listing At | BSE, NSE |
Gland PharmaLimited Size and Price (Retail)
| Application | Lots | Shares | Amount (Cut-off) |
|---|---|---|---|
| Minimum | 1 | 10 | ₹15,000 |
| Maximum | 13 | 130 | ₹195,000 |
Check IPO Allotment Status:click below
Gland Pharma Limited IPO Allotment
Company Contact Info: |
|---|
| Gland Pharma Limited Sy. No. 143 – 148, 150 and 151 Near Gandi Maisamma ‘X’ Roads D.P. Pally, Dundigal, Dundigal – Gandi Maisamma (M) Medchal-Malkajgiri District Hyderabad 500 043 Telangana, India Tel: +91 40 3051 0999 E-mail: investors@glandpharma.com |
| IPO Registrar Info: |
|---|
| Link Intime India Private Limited C-101, 1st Floor 247 Park Lal Bahadur Shastri Marg Vikhroli (West) Mumbai 400 083 Maharashtra, India Tel: +91 22 4918 6200 Investor e-mail: glandpharma.ipo@linkintime.co.in Website: www.linkintime.co.in |
Gland PharmaLimited IPO Lead Managers:
- Citigroup Global Markets India Private Limited
- Haitong Securities India Private Limited
- Kotak Mahindra Capital Company Limited
- Nomura Financial Advisory And Securities (India) Pvt Ltd
YOU TUBE VIDEO:
